CVS Group (LON:CVSG) Earns “Buy” Rating from Berenberg Bank

CVS Group (LON:CVSG)‘s stock had its “buy” rating reiterated by equities research analysts at Berenberg Bank in a report issued on Thursday, London Stock Exchange reports. They currently have a GBX 2,000 price objective on the stock. Berenberg Bank’s price target indicates a potential upside of 63.13% from the company’s current price.

CVSG has been the topic of several other research reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,700 target price on shares of CVS Group in a report on Monday, July 27th. Jefferies Financial Group lifted their price target on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a research report on Friday, July 31st. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

CVS Group Stock Down 5.8%

CVSG stock opened at GBX 1,226 on Thursday. CVS Group has a 52 week low of GBX 1,062 and a 52 week high of GBX 1,648. The company has a market capitalization of £833.31 million, a price-to-earnings ratio of 17.79, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The firm’s 50-day moving average is GBX 1,289.88 and its two-hundred day moving average is GBX 1,230. The company has a current ratio of 1.07, a quick ratio of 0.90 and a debt-to-equity ratio of 92.34.

CVS Group (LON:CVSG) last issued its quarterly earnings results on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. On average, analysts forecast that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

Insider Buying and Selling at CVS Group

In other CVS Group news, insider Robin Alfonso acquired 768 shares of the stock in a transaction dated Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, with a total value of £9,937.92. Also, insider Joanne Shaw bought 1,592 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was acquired at an average price of GBX 1,287 per share, for a total transaction of £20,489.04. In the last three months, insiders acquired 3,860 shares of company stock valued at $4,956,696. 1.48% of the stock is owned by insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.